Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma

International Journal of Molecular Medicine

Volumn 21, Issue 2, 2008, Pages 153-162

  Liu, Yi Ping ^a   Tan, Yun Nian ^a   Wang, Zhen Lian ^a   Zeng, Liang ^a   Lu, Zhong Xin ^a   Li, Li Li ^a   Luo, Wei ^a   Tang, Min ^a   Cao, Ya ^a  

^a Central South University   (China)

Author keywords

Epstein Barr virus; JAK STAT; Latent membrane protein 1; MAPK ERK; Naso pharyngeal carcinoma

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 HYDROXYANILINO) 6,7 DIMETHOXYQUINAZOLINE; INTERLEUKIN 6; JANUS KINASE 3; JANUS KINASE 3 INHIBITOR; LATENT MEMBRANE PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEUTRALIZING ANTIBODY; ONCOPROTEIN; SERINE; STAT3 PROTEIN; TYROSINE; VIRUS PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 38949131488     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.2.153     Document Type: Article

References (41)

1. Rickinson AB: Epstein-Barr virus in action in vivo. N Engl J Med 338: 1461-1463, 1998.
2. Fahraeus R, Rymo L, Rhim JS and Klein G: Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345: 447-449, 1990.
3. Peng M and Lundgren E: Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 7: 1775-1782, 1992.
4. Eliopoulos AG and Young LS: LMP1 structure and signal transduction. Semin Cancer Biol 11: 435-444, 2001.
5. Hennessy K, Fennewald S, Hummel M, Cole T and Kieff E: A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc Natl Acad Sci USA 81: 7207-7211, 1984.
6. Izumi KM and Kieff ED: The Epstein-Barr virus oncogene product latent membrane protein I engages the tumor necrosis factor receptor- associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc Natl Acad Sci USA 94: 12592-12597, 1997.
7. Huen DS, Henderson SA, Croom-Carter D and Rowe M: The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10: 549-560, 1995.
8. Gires O, Kohlbuber F, Kilger E, Baumann M, Kieser A, Kaiser C, Zeidler R, Scheffer B, Ueffing M and Hammerschmidt W: Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J 18: 3064-3073, 1999.
9. Fanger GR, Gerwins P, Widmann C, Jarpe MB and Johnson GL: MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 7: 67-74, 1997.
10. Lim L, Manser E, Leung T and Hall C: Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. Eur J Biochem 242: 171-185, 1996.
11. Symons M: Rho family GTPases: the cytoskeleton and beyond. Trends Biochem Sci 21: 178-181, 1996.
12. Hu Z, Zeng L, Tao YG, Tang FQ, Wang H, Luo FJ, Yi W and Cao Y: EB virus-encoded latent membrane protein 1 activates the JNK signalling pathway via a mechanism involving TRADD and TRAF in nasopharyngeal carcinoma cell. Prog Biochem Biophys 29: 562-566, 2002.
13. Zeng L, Li M, Song X, Tao YG, Tang M, Li W and Cao Y: Epstein-barr virus latent membrane protein 1 (LMP1) activated Ets-1 expression mediated by ERK in nasopharyngeal cell line. Prog Biochem Biophys 30: 574-578, 2003.
14. Yang J, Chatterjee-Kishore M, Staugaitis SM, Nguyen H, Schlessinger K, Levy DE and Stark GR: Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res 65: 939-947, 2005.
15. Bienvenu F, Barre B, Giraud S, Avril S and Coqueret O: Transcriptional regulation by a DNA-associated form of cyclin D1. Mol Biol Cell 16: 1850-1858, 2005.
16. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, et al: STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23: 4921-4929, 2004.
17. Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, et al: Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10: 48-54, 2004.
18. Cheng F, Wang HW, Cuenca A, Huang M, Ghansah T, Brayer J, Kerr WG, Takeda K, Akira S, Schoenberger SP, et al: A critical role for Stat3 signaling in immune tolerance. Immunity 19: 425-436, 2003.
19. Vultur A, Cao J, Arulanandam R, Turkson J, Jove R, Greer P, Craig A, Elliott B and Raptis L: Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene 23: 2600-2616, 2004.
20. Hua Yu RJ: The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 4: 97-105, 2004.
21. Rivat C, De Wever O, Bruyneel E, Marcel M, Gespach C and Attoub S: Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell-cell adhesion complexes. Oncogene 23: 3317-3327, 2004.
22. Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R and Huang S: Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23: 3550-3560, 2004.
23. Chen H, Lee JM, Zong Y, Borowitz M, Ng MH, Ambinder RF and Hayward SD: Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J Virol 75: 2929-2937, 2001.
24. Schuringa JJ, Schepers H, Vellenga E and Kruijer W: Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett 495: 71-76, 2001.
25. Turkson J and Jove R: STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19: 6613-6626, 2000.
26. O'Rourke L and Shepherd PR: Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding. Biochem J 364: 875-879, 2002.
27. Chen H, Hutt-Fletcher L, Cao L and Hayward SD: A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol 77: 4139-4148, 2003.
28. Tan YN, Tao YG, Li LL and Cao Y: Stat3 pathway is activated by EB virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells. EBV Symposium 148, 2004.
29. Tan YN, Tao YG, Li LL, Liu SF, Tang M, Gu HH and Cao Y: Regulation of human VEGF by expression latent membrane protein I encoded by EB virus via STAT3 in nasopharyngeal carcinoma cell line. Prog Biochem Biophys 31: 427, 2004.
30. Liao W, Yi H, Li XY, Tang M, Gu HH and Cao Y: Doxycycline-dependent expression of Epstein-Barr virus latent membrane protein 1 with Tet regulating system in nasopharygeal carcinoma cell line. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 31: 309-312, 1999.
31. Barata JT, Boussiotis VA, Yunes JA, Ferrando AA, Moreau LA, Veiga JP, Sallan SE, Look AT, Nadler LM and Cardoso AA: IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL. Blood 103: 1891-1900, 2004.
32. Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, Mao C and Uckun FM: Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res 5: 1569-1582, 1999.
33. Tibbles HE, Vassilev A, Wendorf H, Schonhoff D, Zhu D, Lorenz D, Waurzyniak B, Liu XP and Uckun FM: Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. J Biol Chem 276: 17815-17822, 2001.
34. Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995.
35. Tanaka K AM and Sato Y: Roles of extracellular signal-regulated kinase 1/ 2 and p38 mitogen-activated protein in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn J Cancer Res 90: 647-654, 1999.
36. Ng J and Cantrell D: STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J Biol Chem 272: 24542-24549, 1997.
37. Chung J, Uchida E, Grammer TC and Blenis J: STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17: 6508-6516, 1997.
38. Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S and Jove R: Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 19: 7519-7528, 1999.
39. Jain N, Zhang T, Kee WH, Li W and Cao X: Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem 274: 24392-24400, 1999.
40. Taga T and Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15: 797-819, 1997.
41. Kishimoto T, Taga T and Akira S: Cytokine signal transduction. Cell 76: 253-262, 1994.